Symbol="SLDB"
AssetType="Common Stock"
Name="Solid Biosciences LLC"
Description="Solid Biosciences Inc., a life sciences company, is dedicated to developing therapies for Duchenne muscular dystrophy (DMD) in the United States. The company is headquartered in Cambridge, Massachusetts."
CIK="1707502"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="141 PORTLAND STREET, FIFTH FLOOR, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="84482000"
EBITDA="-103530000"
PERatio="None"
PEGRatio="None"
BookValue="9.39"
DividendPerShare="0"
DividendYield="0"
EPS="-7.96"
RevenuePerShareTTM="0.535"
ProfitMargin="0"
OperatingMarginTTM="-17.17"
ReturnOnAssetsTTM="-0.303"
ReturnOnEquityTTM="-0.491"
RevenueTTM="6169000"
GrossProfitTTM="13620000"
DilutedEPSTTM="-7.96"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="7.33"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="11.89"
PriceToBookRatio="0.904"
EVToRevenue="1.156"
EVToEBITDA="-0.15"
Beta="1.359"
num_52WeekHigh="14.25"
num_52WeekLow="3.4"
num_50DayMovingAverage="5.55"
num_200DayMovingAverage="5.9"
SharesOutstanding="19601500"
DividendDate="None"
ExDividendDate="None"
symbol="SLDB"
open="4.25"
high="4.26"
low="4.05"
price="4.13"
volume="13048.00"
latest_trading_day="2023-08-01"
previous_close="4.31"
change="-0.18"
change_percent="-4.1763%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="58"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="42"
Volume_recent_avg="30895"
Change_recent_avg="0.01"
Delta_recent_avg="0.27"
Variance_recent_avg="0.14"
Change_ratio_recent_avg="-0.17"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="42"
Aroon_momentum_negative="58"
image_negative_thumbnail_id_1="497"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0108.jpeg"
image_negative_thumbnail_id_2="1145"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0178.jpeg"
image_neutral_thumbnail_id_1="548"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0051.jpeg"
image_neutral_thumbnail_id_2="541"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0058.jpeg"
image_positive_thumbnail_id_1="693"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0015.jpeg"
image_positive_thumbnail_id_2="1015"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0177.jpeg"
image_professor_thumbnail_id_1="1196"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
image_professor_thumbnail_id_2="1190"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
